Ajooni Biotech Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Gursimran Singh
Chief executive officer
₹1.2m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 4.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.8yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital
Oct 11
Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Sep 04Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up
Jul 12Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower
Mar 20We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Nov 10We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Jul 13If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late
Feb 16Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 14
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?
Dec 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹22m |
| Mar 31 2024 | ₹1m | ₹1m | ₹22m |
| Dec 31 2023 | n/a | n/a | ₹18m |
| Sep 30 2023 | n/a | n/a | ₹15m |
| Jun 30 2023 | n/a | n/a | ₹12m |
| Mar 31 2023 | ₹1m | ₹1m | ₹11m |
| Dec 31 2022 | n/a | n/a | ₹5m |
| Sep 30 2022 | n/a | n/a | ₹9m |
| Jun 30 2022 | n/a | n/a | ₹11m |
| Mar 31 2022 | ₹2m | ₹2m | ₹10m |
| Dec 31 2021 | n/a | n/a | ₹11m |
| Sep 30 2021 | n/a | n/a | ₹7m |
| Jun 30 2021 | n/a | n/a | ₹4m |
| Mar 31 2021 | ₹540k | ₹540k | ₹4m |
Compensation vs Market: Gursimran's total compensation ($USD14.27K) is below average for companies of similar size in the Indian market ($USD42.81K).
Compensation vs Earnings: Gursimran's compensation has been consistent with company performance over the past year.
CEO
Gursimran Singh (36 yo)
4.3yrs
Tenure
₹1,200,000
Compensation
Mr. Gursimran Singh had been the Chief Financial Officer of Prism Medico and Pharmacy Limited December 4, 2017 until May 16, 2023 and served as its Executive Director from April 01, 2017 to October 5, 2019...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 7.3yrs | ₹3.00m | 13.96% ₹ 193.6m | |
| CEO & Whole Time Director | no data | ₹1.20m | no data | |
| Executive & Non-Independent Director | 7.4yrs | ₹300.00k | no data | |
| Company Secretary & Compliance Officer | 4.8yrs | ₹571.00k | no data |
4.8yrs
Average Tenure
36yo
Average Age
Experienced Management: AJOONI's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 7.3yrs | ₹3.00m | 13.96% ₹ 193.6m | |
| CEO & Whole Time Director | 4.3yrs | ₹1.20m | no data | |
| Executive & Non-Independent Director | 7.4yrs | ₹300.00k | no data | |
| Independent Non-Executive Woman Director | 7.3yrs | ₹30.00k | 0.037% ₹ 510.1k | |
| Independent Non-Executive Director | 7.3yrs | ₹30.00k | no data | |
| Independent Non-Executive Director | 7.3yrs | ₹30.00k | no data |
7.3yrs
Average Tenure
36.5yo
Average Age
Experienced Board: AJOONI's board of directors are considered experienced (7.3 years average tenure).